Pharmacogenomics Market Size, Share & Industry Analysis, By Type (Products {Consumables and Equipment} and Services), By Techniques (Next Generation Sequencing, Polymerase Chain Reaction, Microarrays, In-situ Hybridization, and Others), By Application (Personalized Medicine, Drug Discovery, and Others), By Disease (Oncology, Neurology, Cardiology, and Others), By End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Others), and Regional Forecast, 2026-2034

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Estimated Year

2026

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 9.95% from 2026-2034

Unit

Value (USD Billion)

Segmentation

By Type

• Products
  • Consumables
  • Equipment
• Services

By Technique

• Next Generation Sequencing
• Polymerase Chain Reaction
• Microarrays
• In-situ Hybridization
• Others

By Application

• Personalized Medicine
• Drug Discovery
• Others

  By Disease

• Oncology
• Neurology
• Cardiology
• Others

By End-user

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Others

By Region

• North America (By Type, Technique, Application, Disease, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Type, Technique, Application, Disease, End-user, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (By Type, Technique, Application, Disease, End-user, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America (By Type, Technique, Application, Disease, End-user, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, Technique, Application, Disease, End-user, and Country/Sub-region)
  • GCC
  • South Africa
  • Middle East & Africa